Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer

Optimal debulking followed by chemotherapy is the standard treatment of managing late-stage ovarian cancer, but chemoresistance is still a major problem. In this study, we compared expression profiles of primary tumor tissue from five long-term (>8 years) and five short-term (<2 years) ovarian...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Park, Dong Choon, Yeo, Seung Geun, Wilson, Mark R, Yerbury, Justin J, Kwong, Joseph, Welch, William R, Choi, Yang Kyu, Birrer, Michael J, Mok, Samuel C, Wong, Kwong-Kwok
Format: Artigo
Sprache:Inglês
Veröffentlicht: Neoplasia Press Inc. 2008
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2517641/
https://ncbi.nlm.nih.gov/pubmed/18714397
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge